AJCC Cancer Staging Atlas

Description:

Significantly expanded, expertly and beautifully illustrated, The AJCC Cancer Staging Atlas, 2nd Edition, offers more than 600 illustrations created exclusively for this new edition and is fully updated to reflect the concepts discussed in the 7th Edition of both the AJCC Cancer Staging Manual and its companion Handbook. This Atlas illustrates the TNM classifications of all cancer sites and types included in the 7th Edition of the Manual and visually conceptualizes the TNM classifications and stage groupings. Specifically designed for simplicity and precision, the drawings have been verified through multi-disciplinary review to ensure accuracy and relevancy for clinical use. Every illustration provides detailed anatomic depictions to clarify critical structures and to allow the reader to instantly visualize the progressive extent of malignant disease. In addition, nodal maps are included for each site, appropriate labeling has been incorporated to identify significant anatomic structures, and each illustration is accompanied by an explanatory legend. The AJCC Cancer Staging Atlas, 2nd Edition, is an official publication of the American Joint Committee on Cancer, the recognized international leader in state-of-the-art information on cancer staging. This Atlas has been created as a companion to the updated 7th Edition of the AJCC Cancer Staging Manual, which continues to disseminate the importance of anatomical and pathological staging in the management of cancer. This state-of-the-art, invaluable 2nd Edition includes a CD containing PowerPoint slides of all illustrations, additional color, and a user-friendly, easy-to-read layout. The AJCC Cancer Staging Atlas, 2nd Edition will serve as an indispensable reference for clinicians, registrars, students, trainees, and patients.

Contents:

Preface; Acknowledgment of Contributors; PART I: General Information on Cancer Staging and End-Results Reporting; Purposes and Principles of Cancer Staging; Cancer Survival Analysis; PART II: Head and Neck; Lip and Oral Cavity; Pharynx; Larynx; Nasal Cavity and Paranasal Sinuses; Major Salivary Glands (Parotid, Submandibular, and Sublingual); Thyroid; Mucosal Melanoma of the Head and Neck; PART III: Digestive System; Esophagus and Esophagogastric Junction; Stomach; Small Intestine; Appendix; Colon and Rectum; Anus; Gastrointestinal Stromal Tumor; Neuroendocrine Tumors; Liver; Intrahepatic Bile Ducts; Gallbladder; Perihilar Bile Ducts; Distal Bile Duct; Ampulla of Vater; Exocrine and Endocrine Pancreas; PART IV: Thorax; Lung; Pleural Mesothelioma; PART V: Musculoskeletal Sites; Bone; Soft Tissue Sarcoma; PART VI: Skin; Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas; Merkel Cell Carcinoma; Melanoma of the Skin; PART VII: Breast; Breast; PART VIII: Gynecologic Sites; Vulva; Vagina; Cervix Uteri; Corpus Uteri; Ovary and Primary Peritoneal Carcinoma; Fallopian Tube; Gestational Trophoblastic Tumors; PART IX: Genitourinary Sites; Penis; Prostate; Testis; Kidney; Renal Pelvis and Ureter; Urinary Bladder; Urethra; Adrenal; PART X: Lymphoid Neoplasms; Hodgkin and Non-Hodgkin Lymphomas; Primary Cutaneous Lymphomas.